David Stokoe

发表

Preservation at Syracuse University Library

Peter D Verheyen, Robert J Hodge, Marianne Swanberry Hanley, 2011 .

Disruption of PH–kinase domain interactions leads to oncogenic activation of AKT in human cancers

Somasekar Seshagiri, Thomas D. Wu, Jeremy Stinson, 2012, Proceedings of the National Academy of Sciences.

A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma.

William A Weiss, David Stokoe, Kevan M Shokat, 2006, Cancer cell.

A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling

Robbie Loewith, William A. Weiss, Kevan M. Shokat, 2006, Cell.

EGFR Signals to mTOR Through PKC and Independently of Akt in Glioma

Frank McCormick, William A Weiss, David Stokoe, 2009, Science Signaling.

Comparative oncogenomics identifies PSMB4 and SHMT2 as potential cancer driver genes.

Somasekar Seshagiri, Li Li, Richard Bourgon, 2014, Cancer research.

Rational design of a nonpeptide general chemical scaffold for reversible inhibition of PDZ domain interactions.

Irwin D Kuntz, Jose J. Haresco, R Kiplin Guy, 2007, Bioorganic & medicinal chemistry letters.

High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma.

Frank McCormick, David Stokoe, Y. Taketani, 2005, Cancer research.

A pharmacological map of the PI3-K family defines a role for p110 alpha in signaling: The structure of complex of phosphoinositide 3- kinase gamma with inhibitor PIK-39

Robbie Loewith, William A. Weiss, B. Gonzalez, 2006 .

Erratum: EGFR signals to mTOR through PKC and independently of Akt in glioma (Science Signaling (2009) 2:60 (er4))

William A. Weiss, Frank McCormick, Kevan M. Shokat, 2009 .

Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC

Gordon Mills, Garret Yount, David Stokoe, 1998, Current Biology.

Akt activation by growth factors is a multiple-step process: the role of the PH domain

Frank McCormick, Alfonso Bellacosa, David Stokoe, 1998, Oncogene.

Identification of Mutant K-Ras-dependent Phenotypes Using a Panel of Isogenic Cell Lines*

Li Li, Jung-Sik Kim, Takehiko Sasazuki, 2012, The Journal of Biological Chemistry.

A selective irreversible inhibitor targeting a PDZ protein interaction domain.

Irwin D Kuntz, Jose J. Haresco, R Kiplin Guy, 2003, Journal of the American Chemical Society.

Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins

David Stokoe, P. Cohen, M. Gaestel, 1992, FEBS letters.

New insights into PTEN

David Stokoe, D. Stokoe, Tanja Tamguney, 2007, Journal of Cell Science.

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

Koji Yoshimoto, Rameen Beroukhim, Paul S Mischel, 2005, The New England journal of medicine.

Genetic Alterations and Oncogenic Pathways Associated with Breast Cancer Subtypes

Thomas D. Wu, Brock A. Peters, Guy Cavet, 2009, Molecular Cancer Research.